DIANA WILLA BIANCHI
Physician in Boston, MA
License number
Massachusetts MD10302
Issued Date
4, 2000
Expiration Date
6, 2008
Category
Physician
Type
Allopathic Physician (MD)
Address
Address
Boston, MA
Education
Stanford University School of Medicine, 6, 1980
Personal information
See more information about DIANA WILLA BIANCHI at radaris.comName
Address
Phone
56 Pier 7, Charlestown, MA 02129
6 Perry St APT 4, Brookline, MA 02445
4 Perry St, Brookline, MA 02445
56 Pier 7, Charlestown, MA 02129
1 Post Office Sq, Boston, MA 02109
Professional information
See more information about DIANA WILLA BIANCHI at trustoria.com
Physician-Scientist With Expertise In Fetal And Neonatal Personalized Medicine
Physician-Scientist With Expertise In Fetal And Neonatal Personalized Medicine
Location:
Greater Boston Area
Industry:
Hospital & Health Care
Diana W Bianchi, Boston MA
Diana W Bianchi, Boston MA
Specialties:
Pediatrician
Address:
750 Washington St, Boston, MA 02111
800 Washington St, Boston, MA 02111
800 Washington St, Boston, MA 02111
Education:
Stanford University, School of Medicine - Doctor of Medicine*
Children's Hospital Boston - Fellowship - Neonatology*
Children's Hospital Boston - Residency - Pediatrics*
Children's Hospital Boston - Fellowship - Neonatology*
Children's Hospital Boston - Residency - Pediatrics*
Board certifications:
American Board of Medical Genetics Certification in Clinical Genetics (MD) (Medical Genetics)*, American Board of Pediatrics Certification in Pediatrics*, American Board of Pediatrics Sub-certificate in Neonatal-Perinatal Medicine (Pediatrics)*
Diana Bianchi, Boston MA
Diana Bianchi, Boston MA
Work:
Tufts Medical Center
800 Washington St, Boston, MA 02111 Tufts University
750 Washington St, Boston, MA 02111
800 Washington St, Boston, MA 02111 Tufts University
750 Washington St, Boston, MA 02111
Dr. Diana W Bianchi, Boston MA - MD (Doctor of Medicine)
Dr. Diana W Bianchi, Boston MA - MD (Doctor of Medicine)
Specialties:
Neonatal Medicine
Address:
Tufts Medical Center Genetics and Metabolism
800 Washington St, Boston 02111
(617) 636-8100 (Phone)
TUFTS-NEW ENGLAND MEDICAL CTR
750 Washington St SUITE 394, Boston 02111
(617) 636-1468 (Phone), (617) 636-1469 (Fax)
800 Washington St, Boston 02111
(617) 636-8100 (Phone)
TUFTS-NEW ENGLAND MEDICAL CTR
750 Washington St SUITE 394, Boston 02111
(617) 636-1468 (Phone), (617) 636-1469 (Fax)
Certifications:
Clinical Genetics, 1987, Pediatrics, 1985, Perinatal Medicine & Neonatal Medicine, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Tufts Medical Center Genetics and Metabolism
800 Washington St, Boston 02111
TUFTS-NEW ENGLAND MEDICAL CTR
750 Washington St SUITE 394, Boston 02111
Women & Infants Hospital
101 Dudley St, Providence 02905
800 Washington St, Boston 02111
TUFTS-NEW ENGLAND MEDICAL CTR
750 Washington St SUITE 394, Boston 02111
Women & Infants Hospital
101 Dudley St, Providence 02905
Education:
Medical School
Stanford University
Graduated: 1980
Childrens Hospital
Stanford University
Graduated: 1980
Childrens Hospital
Prenatal Diagnosis Using Cell-Free Fetal Dna In Amniotic Fluid
Prenatal Diagnosis Using Cell-Free Fetal Dna In Amniotic Fluid
US Patent:
2007021, Sep 13, 2007
Filed:
Oct 29, 2004
Appl. No.:
10/577341
Inventors:
Diana Bianchi - Charlestown MA, US
Paige Larrabee - Portland OR, US
Kirby Johnson - Quincy MA, US
Paige Larrabee - Portland OR, US
Kirby Johnson - Quincy MA, US
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
The present invention relates to improved methods of prenatal diagnosis, screening, monitoring and/or testing. The inventive methods include the analysis by array-based hybridization of cell-free fetal DNA isolated from amniotic fluid. In addition to allowing the prenatal diagnosis of a variety of diseases and conditions, and the assessment of fetal characteristics such as fetal sex and chromosomal abnormalities, the new inventive methods provide substantially more information about the fetal genome in less time than it takes to perform a conventional metaphase karyotype analysis. In particular, the enhanced molecular karyotype methods provided by the present invention allow the detection of chromosomal aberrations that are not often detected prenatally such as microdeletions, microduplications and subtelomeric rearrangements.
Analyzing Neonatal Saliva And Readiness To Feed
Analyzing Neonatal Saliva And Readiness To Feed
US Patent:
2013026, Oct 3, 2013
Filed:
Mar 12, 2013
Appl. No.:
13/796843
Inventors:
KIRBY L. JOHNSON - NORTH ATTLEBORO MA, US
DIANA W. BIANCHI - CHARLESTOWN MA, US
DIANA W. BIANCHI - CHARLESTOWN MA, US
Assignee:
TUFTS MEDICAL CENTER, INC. - BOSTON MA
International Classification:
C12Q 1/68
US Classification:
506 9, 435 611
Abstract:
The present invention provides systems for assessing neonatal development and/or conditions by analyzing neonatal saliva RNA. Methods of identifying genes involved in neonatal development and/or conditions affecting neonates, are provided. Methods of determining a diagnosis of a neonate comprising detection of one or more differentially expressed genes are also provided.
Genomic Approaches To Fetal Treatment And Diagnosis
Genomic Approaches To Fetal Treatment And Diagnosis
US Patent:
2011015, Jun 23, 2011
Filed:
Jun 1, 2009
Appl. No.:
12/993881
Inventors:
Donna Slonim - North Andover MA, US
Kirby Johnson - North Attleboro MA, US
Diana Bianchi - Charlestown MA, US
Kirby Johnson - North Attleboro MA, US
Diana Bianchi - Charlestown MA, US
International Classification:
A61K 49/00, C40B 30/02, A61K 31/56, A61K 31/137, A61K 31/44, A61K 33/34, A61K 31/19, A61K 31/5415, A61K 31/395, A61K 31/60, A61K 31/4355, A61K 31/196, A61K 31/52, A61K 31/405, A61K 31/352, A61K 31/337, A61K 31/047, A61K 31/55, A61K 31/54, A61K 31/517, A61K 31/167, A61K 31/706, A61K 31/415, A61K 31/566, A61K 31/4164, A61K 31/195, A61K 31/197, A61K 31/201, A61K 31/407, C12Q 1/68, A61P 43/00
US Classification:
424 92, 506 8, 514181, 514654, 514356, 424637, 514573, 5142278, 514183, 514165, 514291, 514567, 5142633, 514420, 514456, 514449, 514729, 514217, 5142258, 51425217, 514619, 514 43, 514396, 514177, 514399, 514561, 514557, 514560, 514411, 435 611
Abstract:
The present invention provides systems for developing and/or testing therapies for prenatal diseases and conditions including Down Syndrome. The present invention also provides diagnostic methods for Down Syndrome involving, in some embodiments, gene expression analyses of fetal RNA and/or detection of expression of particular genes involved in Down Syndrome. Also provided are microarrays and kits useful in prenatal diagnostic applications.
Neonatal Salivary Genomics
Neonatal Salivary Genomics
US Patent:
2011011, May 19, 2011
Filed:
May 1, 2009
Appl. No.:
12/990855
Inventors:
Jill Maron - Sharon MA, US
Diana Bianchi - Charlestown MA, US
Kirby Johnson - North Attleboro MA, US
Donna Slonim - North Andover MA, US
Diana Bianchi - Charlestown MA, US
Kirby Johnson - North Attleboro MA, US
Donna Slonim - North Andover MA, US
International Classification:
C40B 20/04, C12Q 1/68
US Classification:
506 4, 435 6
Abstract:
The present invention provides systems for assessing neonatal development and/or conditions by analyzing neonatal saliva RNA. Methods of identifying genes involved in neonatal development and/or conditions affecting neonates, are provided. Methods of determining a diagnosis of a neonate comprising detection of one or more differentially expressed genes are also provided.
Diagnosis Of Fetal Abnormalities Using Nucleated Red Blood Cells
Diagnosis Of Fetal Abnormalities Using Nucleated Red Blood Cells
US Patent:
2009018, Jul 16, 2009
Filed:
Jul 11, 2008
Appl. No.:
12/172158
Inventors:
Ravi Kapur - Stoughton MA, US
Diana Bianchi - Charlestown MA, US
Tom Barber - Allston MA, US
Mehmet Toner - Wellesley Hills MA, US
Diana Bianchi - Charlestown MA, US
Tom Barber - Allston MA, US
Mehmet Toner - Wellesley Hills MA, US
International Classification:
C12Q 1/06
US Classification:
435 39
Abstract:
The present invention relates to methods for diagnosing a condition in a fetus by enriching and enumerating circulating red blood cells with the possible combination of results from maternal serum marker screens.